ZBIO · trading date Oct 12, 2026 · previous close $27.26 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$10.00M
Net income
-$377.74M
Total assets
$383.64M
Total liabilities
$141.50M
Stockholders' equity
$242.14M
Cash & equivalents
$110.64M
Operating income
-$383.06M
Operating cash flow
-$172.33M
Capital expenditures
$18.0K
Fiscal year 2025, via 10-K filed 2026-03-16.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-3,830.6%
Net margin
-3,777.4%
Free cash flow
-$172.35M
Free cash flow margin
-1,723.5%
Liabilities / assets
36.9%
Equity / assets
63.1%
CapEx / revenue
0.2%
Operating cash flow / net income
0.46×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Waltham, MA 02451
852 WINTER STREET, SUITE 250
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:35 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.